National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]
1994 • 6,495 citations
Clinical staging of chronic lymphocytic leukemia
1975 • 2,706 citations
p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias
1995 • 749 citations
bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
1993 • 660 citations
Fludarabine: a new agent with major activity against chronic lymphocytic leukemia
1989 • 466 citations
A clinical staging system for chronic lymphocytic leukemia.Prognostic significance
1977 • 410 citations
p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression
1993 • 372 citations
Bone marrow histologic pattern--the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases
1984 • 325 citations
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]
1993 • 292 citations
HLA-Identical Sibling Bone Marrow Transplantation in Younger Patients with Chronic Lymphocytic Leukemia
1996 • 256 citations
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
1991 • 255 citations
Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent
1993 • 244 citations
Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: preliminary results.
1994 • 195 citations
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]
1992 • 176 citations
Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia
1993 • 168 citations
High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.
1993 • 147 citations
Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses
1995 • 142 citations
Evidence for a new tumour suppressor locus (DBM) in human B–cell neoplasia telomeric to the retinoblastoma gene
1993 • 135 citations
High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics
1993 • 127 citations
Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia
1993 • 114 citations
True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases [see comments]
1995 • 106 citations
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
1994 • 98 citations
Progression and survival studies in early chronic lymphocytic leukemia
1991 • 81 citations
Manual of oncologic therapeutics
1991 • 67 citations
Deleted Work
1955 • 0 citations
Cited By (0)
No citing papers found in database